FOXP1 and prostate carcinoma: Loss of FoxP1 function has been reported in several human malignancies such as endometrial cancer, lung cancer, head and neck cancer, prostate cancer, renal cell carcinoma, ovarian carcinoma, and has been shown to be associated with poor prognosis in breast cancer [8, 10, 11].